Hyperferritinemia at diagnosis predicts relapse and overall survival in younger AML patients with intermediate-risk cytogenetics

Leukemia Research - Tập 39 - Trang 818-821 - 2015
Delphine Lebon1, François Vergez2,3, Sarah Bertoli4, Véronique Harrivel5, Stéphane De Botton6, Jean-Baptiste Micol6, Jean-Pierre Marolleau7, Christian Récher4,3
1Service d’Hématologie Clinique, CHU Amiens, Amiens Cedex 1, France
2Laboratoire d’Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
3Université Toulouse III Paul Sabatier, Toulouse, France;
4Service d’Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
5Laboratoire d’Hématologie, CHU Amiens, Amiens Cedex 1, France
6Service d’hématologie Clinique, Institut Gustave Roussy, Villejuif, France
7Service d’Hématologie Clinique, Université de Picardie Jules Verne, CHU Amiens, Amiens Cedex 1, France

Tài liệu tham khảo

Armand, 2007, Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation, Blood, 109, 4586, 10.1182/blood-2006-10-054924 Armand, 2012, Does iron overload really matter in stem cell transplantation?, Am J Hematol, 87, 569, 10.1002/ajh.23188 Bazuaye, 2012, Prognostic impact of iron parameters in patients undergoing allo-SCT, Bone Marrow Transplant, 47, 60, 10.1038/bmt.2011.13 Mahindra, 2009, Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation, Br J Haematol, 146, 310, 10.1111/j.1365-2141.2009.07774.x Lim, 2010, Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation, Leuk Res, 34, 723, 10.1016/j.leukres.2009.10.028 Cazzola, 2008, Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes, Hematology Am Soc Hematol Educ Program, 166, 10.1182/asheducation-2008.1.166 Delavigne, 2014, Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy, Haematologica, 99, 474, 10.3324/haematol.2013.097394 Thomas, 2011, Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study, Blood, 118, 1754, 10.1182/blood-2011-04-349258 Recher, 2014, Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia, Leukemia, 28, 440, 10.1038/leu.2013.290 Grimwade, 2010, Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials, Blood, 116, 354, 10.1182/blood-2009-11-254441 Cheson, 2003, Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia, J Clin Oncol, 21, 4642, 10.1200/JCO.2003.04.036 Alkhateeb, 2013, The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis, Biochim Biophys Acta, 1836, 245 Arosio, 2009, Ferritins: a family of molecules for iron storage, antioxidation and more, Biochim Biophys Acta, 1790, 589, 10.1016/j.bbagen.2008.09.004 Kikyo, 1995, Growth stimulation of ferritin of human leukemia cells in vitro, J. Cancer Res Clin Oncol, 121, 76, 10.1007/BF01202216